CABA - CIK 0001759138
The table below shows Cabaletta Bio, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $82.98M | $163.96M | $193.24M | $81.61M | $122.22M | $101.43M |
| Short-term investments | $50.62M | $0.00 | $48.01M | $24.94M | $7.23M | $7.23M |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $138.87M |
| $166.68M |
| $244.49M |
| $108.83M |
| $124.54M |
| $113.53M |
| Property, plant & equipment | $1.92M | $2.74M | $2.54M | $2.58M | $1.44M | $890.00K |
| Goodwill | - | - | - | - | - | - |
| Total assets | $165.08M | $185.05M | $253.65M | $116.97M | $126.34M | $114.72M |
| Accounts payable | $6.64M | $4.92M | $4.55M | $2.46M | $2.33M | $1.24M |
| Total current liabilities | $50.15M | $27.09M | $15.99M | $9.49M | $8.38M | $5.18M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $53.03M | $32.71M | $17.45M | $12.45M | - | - |
| Retained earnings | -$516.96M | -$349.10M | -$233.24M | -$165.56M | -$112.59M | -$66.30M |
| Total equity | $112.05M | $152.34M | $236.20M | $104.52M | $117.96M | $109.54M |